Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2024 01:30 ET | Source: CROSSJECT

Crossject annonce son éligibilité au dispositif d’investissement PEA-PME

Le PEA-PME permet aux investisseurs particuliers français d'acheter des titres à des conditions fiscales préférentielles. Dijon, Sept 26, 2024 -- Crossject (ISIN : FR0011716265 ; Euronext : ALCJ),...
September 26, 2024 01:30 ET | Source: CROSSJECT

Crossject announces its eligibility for France’s PEA-PME investment scheme

Enables French retail investors to buy securities under preferential tax conditions Dijon, France Sept 26, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company...
September 26, 2023 11:35 ET | Source: CROSSJECT

Crossject reports financial results and business highlights for first half of 2023

Press Release Crossject reports financial results and business highlights for first half of 2023 Strong progress in bringing drugs for use in emergency situations towards the market ...
September 26, 2023 11:35 ET | Source: CROSSJECT

Crossject présente ses résultats financiers et faits marquants du premier semestre 2023

Communiqué de presse Crossject présente ses résultats financiers et faits marquants du premier semestre 2023 De solides avancées vers la mise sur le marché de médicaments dédiés aux situations...